Mason Hayes & Curran launches dedicated life sciences website

Mason Hayes & Curran launches dedicated life sciences website

Michaela Herron

Business law firm Mason Hayes & Curran has launched a new dedicated website to help life sciences companies stay compliant and competitive.

Capsule addresses the growing complexity facing life sciences companies as they navigate evolving regulatory frameworks, and brings together the firm’s expertise across six key sectors: medical devices, pharmaceuticals, digital health, cosmetics, food and chemicals.

The platform provides sector-specific insights, regulatory updates, practical analysis and details of upcoming events, designed to support businesses from Fortune 100 leaders to emerging innovators.

The site also includes updates on emerging legislation and insights into regulatory requirements, creating a one-stop shop knowledge resource for life sciences companies.

The launch reflects increasing demand for specialised legal counsel in Ireland’s expanding life sciences sector, the firm said.

Recent industry developments, including enhanced regulatory oversight and post-Brexit market changes, have created additional compliance challenges for companies operating across EU and global markets. The new resource aims to assist clients and stakeholders with navigating those challenges.

Michaela Herron, partner and head of life sciences at Mason Hayes & Curran, said: “Life sciences companies face an increasingly complex regulatory environment. Capsule provides the practical clarity that businesses need to navigate change confidently.

“Our sectoral expertise, combined with strong commercial insight, helps clients anticipate challenges and maintain momentum in tightly regulated markets.

“The site reflects our commitment to supporting life sciences clients and stakeholders operating in the EU market. Our aim is to provide practical support that helps teams move faster, reduces escalation risk, and keeps products on the market.”

Mason Hayes & Curran has been home to Ireland’s only dedicated and standalone life sciences regulatory team since 2019.

Share icon
Share this article: